KCNIP4 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-84105
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Format
BSA Free
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N terminal region of human KCNIP4. Peptide sequence: NSTKRSIKERLMKLLPCSAAKTSSPAIQNSVEDELEMATVRHRPEALELL The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for KCNIP4 Antibody - BSA Free
Western Blot: KCNIP4 Antibody [NBP2-84105]
Western Blot: KCNIP4 Antibody [NBP2-84105] - WB Suggested Anti-KCNIP4 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: Jurkat cell lysateImmunohistochemistry: KCNIP4 Antibody [NBP2-84105]
Immunohistochemistry: KCNIP4 Antibody [NBP2-84105] - Human BrainApplications for KCNIP4 Antibody - BSA Free
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Format
BSA Free
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: KCNIP4
Alternate Names
A-type potassium channel modulatory protein 4, Calsenilin-like protein, KChIP4, KCHIP4CALPMGC44947, Kv channel interacting protein 4, Kv channel-interacting protein 4, potassium channel interacting protein 4, Potassium channel-interacting protein 4
Gene Symbol
KCNIP4
Additional KCNIP4 Products
Product Specific Notices for KCNIP4 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...